| Overall (N=32) |
|
|---|---|
| Age at implantation (years) | |
| Mean (SD) | 67.1 (12.4) |
| Median [Min, Max] | 70.0 [30.0, 84.0] |
| Gender | |
| Male | 15 (46.9%) |
| Female | 17 (53.1%) |
| Preimplant Low-Frequency PTA (dB HL) | |
| Mean (SD) | 45.4 (13.3) |
| Median [Min, Max] | 45.0 [25.0, 71.7] |
| Postimplant Low-Frequency PTA (dB HL) | |
| Mean (SD) | 86.9 (19.4) |
| Median [Min, Max] | 95.0 [50.0, 107] |
| Electrode | |
| HiRes Ultra 3D | 5 (15.6%) |
| Neuro Zti | 6 (18.8%) |
| Nucleus® CI522 | 1 (3.1%) |
| Nucleus® CI622 | 18 (56.3%) |
| Nucleus® CI632 | 1 (3.1%) |
| Missing | 1 (3.1%) |
| Intravenous corticosteroid | |
| No | 9 (28.1%) |
| Yes | 22 (68.8%) |
| Missing | 1 (3.1%) |
| Hyaluronic acid | |
| No | 18 (56.3%) |
| Yes | 13 (40.6%) |
| Missing | 1 (3.1%) |